Atnaujinkite slapukų nuostatas

Kucers' The Use of Antibiotics Sixth Edition: A Clinical Review of Antibacterial, Antifungal and Antiviral Drugs 6th New edition [Multiple-component retail product]

, (Austin Health and University of Melbourne, Australia), , , (Monash University, The Alfred Hospital, and Ma), , (The Alfred Hospital, Melbourne, Victoria, Australia), (University of Queensland and Royal Brisbane and Womens Hospital, Australia)
  • Formatas: Multiple-component retail product, 3223 pages, aukštis x plotis: 276x210 mm, weight: 6000 g, 150 Line drawings, black and white; 150 Illustrations, black and white, Contains 1 Book and 1 Digital (delivered electronically)
  • Išleidimo metai: 29-Oct-2010
  • Leidėjas: Hodder Arnold
  • ISBN-10: 0340927674
  • ISBN-13: 9780340927670
Kitos knygos pagal šią temą:
  • Formatas: Multiple-component retail product, 3223 pages, aukštis x plotis: 276x210 mm, weight: 6000 g, 150 Line drawings, black and white; 150 Illustrations, black and white, Contains 1 Book and 1 Digital (delivered electronically)
  • Išleidimo metai: 29-Oct-2010
  • Leidėjas: Hodder Arnold
  • ISBN-10: 0340927674
  • ISBN-13: 9780340927670
Kitos knygos pagal šią temą:
'I am unaware of any textbook which provides such comprehensive coverage of the field and doubt that this work will be surpassed in the foreseeable future, if ever!'

From the foreword by Robert C. Moellering, Jr., M.D, Shields Warren-Mallinckrodt Professor of Medical Research, Harvard Medical School, USA Kucers' The Use of Antibiotics is the leading major reference work in this vast and rapidly developing field. More than doubled in length compared to the fifth edition, the sixth edition comprises 3000 pages over 2-volumes in order to cover all new and existing therapies, and emerging drugs not yet fully licensed.

Concentrating on the treatment of infectious diseases, the content is divided into 4 sections: antibiotics, anti-fungal drugs, anti-parasitic drugs and anti-viral drugs, and is highly structured for ease of reference.Within each section, each chapter is structured to cover susceptibility, formulations and dosing (adult and paediatric), pharmacokinetics and pharmacodynamics, toxicity and drug distribution, detailed discussion regarding clinical uses, a feature unique to this title.

Compiled by an expanded team of internationally renowned and respected editors, with a vast number of contributors spanning Europe, Africa, Asia, Australia, South America, the US and Canada, the sixth edition adopts a truly global approach. It will remain invaluable for anyone using antimicrobial agents in their clinical practice and provides in a systematic and concise manner all the information required when treating infections requiring antimicrobial therapy.

Kucers' The Use of Antibiotics is available free to purchasers of the books as an electronic version on line or on your desktop:







It provides access to the entire 2-volume print material

It is fully searchable, so you can find the relevant information you need quickly Live references are linked to PubMed referring you to the latest journal material

Customise the contents - you can highlight sections and make notes

Comments can be shared with colleagues/tutors for discussion, teaching and learning

The text can also be reflowed for ease of reading

Text and illustrations copied will be automatically referenced to Kucers' The Use of Antibiotics

Recenzijos

In keeping with its well-earned reputation as the leading and absolute authority on antibiotics, Kucers' remains a must-have for infectious diseases clinicians.



Clinical Infectious Disease 2011



This sixth edition of Kucers' The Use of Antibiotics is one of the most updated comprehensive compendiums on this subject. The book is a must in all hospitals and medical libraries.



Expert Rev. Anti Infect. Ther 2011

Contributors ix
Foreword xix
Obituary xxi
Preface xxiii
Abbreviations xxv
Volume 1
Section I ANTIBIOTICS
Part 1 Penicillins and Related Drugs
Benzylpenicillin (Penicillin G)
5(54)
Phenoxypenicillins
59(6)
Ampicillin, Amoxicillin and Other Ampicillin-Like Penicillins
65(28)
Methicillin
93(7)
Isoxazolyl Pencillins: Oxacillin, Cloxacillin, Dicloxacillin and Flucloxacillin
100(15)
Nafcillin
115(8)
Carbenicillin, Carindacillin, Carfecillin and Ticarcillin
123(12)
Mezlocillin, Azlocillin, Apalcillin and Piperacillin
135(17)
Mecillinam (Amdinocillin) and Pivmecillinam
152(8)
Temocillin
160(7)
Beta-Lactamase Inhibitors and Combinations
Clavulanic Acid
167(8)
Sulbactam
175(5)
Tazobactam and Brobactam
180(7)
Amoxicillin-Clavulanic Acid (Co-Amoxiclav)
187(17)
Ampicillin-Sulbactam
204(17)
Ticarcillin-Clavulanic Acid
221(17)
Piperacillin-Tazobactam
238(19)
Part 2 Cephalosporins and Related Drugs
Cephalothin and Cefazolin
257(11)
Cephalexin
268(7)
Cephadroxil, Cephaloridine, Cephacetrile, Cephapirin, Cephradine, and Other Rarely Used First-Generation Cephalosporins
275(5)
Cefaclor, Cefprozil, and Loracarbef
280(6)
Cefuroxime
286(9)
Cefotiam, Cefuzonam, Cefamandole, Cefonicid and Ceforanide
295(6)
Cefoxitin, Cefotetan and Other Cephamycins (Cefmetazole and Flomoxef)
301(10)
Cefoperazone and Cefoperazone-Sulbactam
311(8)
Cefotaxime
319(32)
Ceftriaxone
351(39)
Ceftizoxime, Cefdinir, Cefditoren, Cefpodoxime, Ceftibuten, Cefsulodin, and Cefpiramide
390(8)
Cefixime
398(7)
Ceftazidime
405(17)
Cefpirome
422(5)
Cefepime
427(15)
Ceftaroline
442(6)
Ceftobiprole
448(10)
Aztreonam
458(13)
Part 3 Carbapenems
Imipenem
471(29)
Meropenem
500(14)
Doripenem
514(12)
Ertapenem
526(16)
Biapenem
542(5)
Faropenem
547(6)
Panipenem
553(5)
Ritipenem
558(4)
Sulopenem
562(7)
Part 4 Glycopeptides and Lipopetides
Vancomycin
569(32)
Teicoplanin
601(20)
Daptomycin
621(17)
Oritavancin
638(7)
Dalbavancin
645(9)
Telavancin
654(7)
Ramoplanin
661(6)
Part 5 Aminoglycosides
Kanamycin
667(7)
Gentamicin
674(25)
Tobramycin
699(13)
Amikacin
712(15)
Sisomicin and Netilmicin
727(9)
Isepamicin
736(6)
Neomycin
742(9)
Part 6 Macrolides and Ketolides
Erythromycin
751(19)
Roxithromycin
770(9)
Clarithromycin
779(22)
Azithromycin
801(18)
Josamycin and Rosaramicin
819(6)
Telithromycin
825(9)
Cethromycin
834(9)
Part 7 Tetracyclines and Related Drugs
Tetracycline
843(8)
Doxycycline
851(19)
Minocycline
870(11)
Tigecycline
881(14)
Part 8 Other Antibiotics
Linezolid
895(25)
Quinupristin-Dalfopristin
920(117)
Pristinamycin
930(5)
Fosfomycin
935(10)
Fusidic Acid (Fusidate Sodium)
945(10)
Polymyxins
955(16)
Novobiocin
971(4)
Bacitracin and Gramicidin
975(5)
Mupirocin
980(7)
Lincomycin and Clindamycin
987(21)
Chloramphenicol and Thiamphenicol
1008(22)
Spectinomycin
1030(7)
Part 9 Anti-Folate Agents and Other Synthetic Antibacterials
Sulfonamides
1037(39)
Trimethoprim, Co-Trimoxazole (Co-T) and Related Agents
1076(74)
Pyrimethamine
1150(14)
Dapsone
1164(18)
Trimetrexate
1182(5)
Iclaprim
1187(8)
Nitrofurans: Nitrofurazone, Furazolidone and Nitrofurantoin
1195(10)
Methenamine Mandelate and Methenamine Hippurate
1205(6)
Part 10 Nitroimidazoles
Metronidazole
1211(27)
Tinidazole
1238(11)
Part 11 Quinolones and Fluoroquinolones
Nalidixic Acid and Other Older Quinolones
1249(16)
Ciprofloxacin
1265(82)
Norfloxacin
1347(15)
Ofloxacin
1362(34)
Levofloxacin
1396(16)
Moxifloxacin
1412(17)
Gatifloxacin
1429(23)
Garenoxacin
1452(14)
Gemifloxacin
1466(9)
Sitafloxacin
1475(7)
Enoxacin
1482(8)
Pefloxacin
1490(11)
Sparfloxacin
1501(8)
Lomefloxacin
1509(8)
Rufloxacin
1517(4)
Tosufloxacin
1521(5)
Fleroxacin
1526(12)
Newer, Discontinued Fluoroquinolones: Temfloxacin, Trovafloxacin, Grepafloxacin, and Clinafloxacin
1538(11)
Part 12 Anti-Tuberculous Drugs
Isoniazid
1549(21)
Ethambutol
1570(11)
Pyrazinamide
1581(6)
Rifampicin (Rifampin)
1587(40)
Rifabutin
1627(10)
Rifaximin
1637(8)
Rifapentine
1645(5)
Streptomycin
1650(12)
Para-Aminosalicylic Acid (PAS)
1662(4)
Ethionamide and Prothionamide
1666(6)
Thiacetazone
1672(5)
Capreomycin
1677(4)
Cycloserine
1681(6)
Viomycin
1687(6)
Volume 2
Section II ANTI-FUNGAL DRUGS
Part 1 Polyenes
Amphotericin B (AMP): Deoxycholate and Lipid Formulations
1693(35)
Nystatin
1728(5)
Natamycin (Pimaricin)
1733(6)
Part 2 Echinocandins, Allylamines and Benzylamine Derivatives
Echinocandins - Caspofungin, Anidulafungin and Micafungin
1739(24)
Terbinafine
1763(9)
Butenafine
1772(4)
Naftifine
1776(5)
Part 3 Systemic Azoles
Ketoconazole
1781(25)
Fluconazole
1806(18)
Itraconazole
1824(20)
Miconazole
1844(8)
Voriconazole
1852(10)
Posaconazole
1862(9)
Ravuconazole
1871(6)
Albaconazole
1877(5)
Isavuconazole
1882(7)
Part 4 Topical Azoles
Bifonazole
1889(4)
Butoconazole
1893(3)
Clotrimazole
1896(7)
Croconazole
1903(2)
Eberconazole
1905(2)
Econazole
1907(4)
Enilconazole
1911(1)
Fenticonazole
1912(3)
Flutrimazole
1915(2)
Isoconazole
1917(2)
Lanoconazole
1919(2)
Neticonazole
1921(2)
Oxiconazole
1923(3)
Sertaconazole
1926(4)
Sulconazole
1930(3)
Terconazole
1933(3)
Tioconazole
1936(3)
KP-103
1939(4)
Part 5 Topical Agents - Thiocarbamates, Hydroxypridones and Morpholine
Tolnaftate
1943(2)
Amorolfine
1945(4)
Ciclopirox
1949(4)
Rilopirox
1953(4)
Part 6 Other Antifungal Agents and New Agents in Development
Flucytosine (5-Fluorocytosine; 5-FC)
1957(7)
Griseofulvin
1964(6)
Haloprogin
1970(2)
New Agents in Development - Nikkomycin Z, CAY-1, Sodarins, Butenolides, Enfungumab, Inositol Phosphocer-amide Synthase Inhibitors
1972(17)
Section III ANTI - PARASITIC DRUGS
Part 1 Anti-Malarial Agents
Chloroquine
1989(14)
Amodiaquine
2003(8)
Quinine and Quinidine
2011(13)
Mefloquine
2024(12)
Halofantrine
2036(6)
Lumefantrine
2042(7)
Primaquine
2049(10)
Piperaquine
2059(9)
Tafenoquine
2068(5)
Atovaquone
2073(9)
Proguanil and Chloroproguanil
2082(8)
Artemisinins
2090(17)
Part 2 Agents Active Against Intestinal and Intra-Abdominal Protozoa
Iodoquinol and Quinacrine
2107(3)
Fumagillin
2110(4)
Furazolidone (Furazolidine)
2114(7)
Diloxanide Furoate
2121(4)
Spiramycin
2125(7)
Nitazoxanide
2132(8)
Paromomycin
2140(11)
Part 3 Agents Active Against American Trypanosomiasis
Benznidazole
2151(4)
Nifurtimox
2155(12)
Part 4 Agents Active Against African Trypanosomiasis
Suramin
2167(10)
Melarsoprol
2177(12)
Eflornithine
2189(14)
Part 5 Agents Active Against Leishmania and Other Pathogens
Pentamidine
2203(5)
Antimonial Agents
2208(6)
Miltefosine
2214(13)
Part 6 Agents Active Against Helminths
Albendazole
2227(13)
Mebendazole
2240(6)
Thiabendazole
2246(4)
Triclabendazole
2250(4)
Ivermectin
2254(9)
Diethylcarbamazine (DEC)
2263(9)
Pyrantel Pamoate
2272(4)
Praziquantel
2276(9)
Oxamniquine
2285(4)
Metrifonate
2289(4)
Niclosamide
2293(6)
Part 7 Agents Active Against Ectoparasites
Permethrin
2299(7)
Piperonyl Butoxide
2306(4)
Lindane
2310(8)
Malathion
2318(7)
Crotamiton
2325(8)
Section IV ANTI-VIRAL DRUGS
Part 1 Agents Active Against Herpesviruses
Aciclovir
2333(28)
Valaciclovir
2361(9)
Famciclovir and Penciclovir
2370(8)
Ganciclovir and Valganciclovir
2378(25)
Cidofovir
2403(26)
Vidarabine
2429(4)
Foscarnet
2433(23)
Maribavir
2456(5)
Trifluridine (Trifluorothymidine)
2461(4)
Idoxuridine
2465(5)
Fomivirsen
2470(9)
Part 2 Agents Active Against the Human Immunodeficiency Virus
Inhibitors of Reserve Transcriptase
Zidovudine
2479(33)
Didanosine
2512(21)
Zalcitabine
2533(12)
Lamivudine
2545(18)
Stavudine (d4T)
2563(12)
Abacavir
2575(20)
Emtricitabine
2595(18)
Tenofovir
2613(14)
Amdoxovir
2627(9)
Apricitabine
2636(9)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Nevirapine
2645(30)
Efavirenz
2675(27)
Delavirdine
2702(9)
Etravirine
2711(12)
Rilpivirine
2723(8)
Inhibitors of HIV Protease
Saquinavir
2731(28)
Ritonavir
2759(17)
Indinavir
2776(12)
Nelfinavir
2788(9)
Lopinavir
2797(12)
Amprenavir and Fosamprenavir
2809(15)
Darunavir
2824(6)
Atazanavir
2830(12)
Tipranavir
2842(19)
Other Anti-HIV Agents
Enfuvirtide
2861(8)
Maraviroc
2869(8)
Raltegravir and Other HIV Integrase Inhibitors
2877(14)
Part 3 Agents Active Against Hepatitis Viruses
Entecavir
2891(8)
Adefovir Dipivoxil
2899(9)
Telbivudine
2908(7)
Torcitabine and Valtorcitabine
2915(3)
Clevudine
2918(5)
Ribavirin and Viramidine
2923(36)
Pegylated Interferon Alfa
2959(17)
Protease and Polymerase Inhibitors for the Treatment of Hepatitis C Virus Infection
2976(17)
Part 4 Agents Active Against Respiratory Viruses
Amantadine and Rimantadine
2993(20)
Zanamivir and Polymeric Zanamivir Conjugates
3013(16)
Oseltamivir
3029(14)
Peramivir
3043(8)
Index 3051
M Lindsay Grayson MB BS MD MSC FRACP FRCP FAFPHM Professor of Medicine and Director, Infectious Disease and Microbiology Departments, Austin Health Department of Epidemiology and Preventative Medicine, Monash University Department of Medicine, University of Melbourne, Melbourne, Australia

Section Editors: Suzanne M Crowe, James S McCarthy, John Mills, Johan W Mouton, S Ragnar Norrby, David L Paterson, Michael A Pfaller